Life Science Analytics published its analysis of the top dealmakers in the pharmaceutical industry in 2010 as reported in Pharmalot below.
Which Drugmaker Did The Most Deals In 2010? // Pharmalot.
Deals included acquisitions, codevelopment, collaborations, co-marketing, co-promotion, and commercialization, distribution and cross distribution, cross licensing, development, licensing manufacturing, supply agreements and sublicensing (say that without taking a breath). So who were the top 10 "deal makers" through October?
- Pfizer 51
- Sanofi-Aventis 50
- Novartis 49
- Roche 46
- GSK 44
- Bayer 31
- Teva 30
- AstraZeneca 25
- Abbott 20
- Lilly 18
This amounts to about 20 more deal activity than in the previous year.
Posted by Bruce Lehr December 9th 2010.
Comments